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ABSTRACT
MPV17 is a mitochondrial protein of unknown func-
tion, and mutations in MPV17 are associated with
mitochondrial deoxyribonucleic acid (DNA) mainte-
nance disorders. Here we investigated its most sim-
ilar relative, MPV17L2, which is also annotated as
a mitochondrial protein. Mitochondrial fractionation
analyses demonstrate MPV17L2 is an integral in-
ner membrane protein, like MPV17. However, un-
like MPV17, MPV17L2 is dependent on mitochondrial
DNA, as it is absent from 0 cells, and co-sediments
on sucrose gradients with the large subunit of the
mitochondrial ribosome and the monosome. Gene
silencing of MPV17L2 results in marked decreases in
the monosome and both subunits of the mitochon-
drial ribosome, leading to impaired protein synthe-
sis in the mitochondria. Depletion of MPV17L2 also
induces mitochondrial DNA aggregation. The DNA
and ribosome phenotypes are linked, as in the ab-
sence of MPV17L2 proteins of the small subunit of
the mitochondrial ribosome are trapped in the en-
larged nucleoids, in contrast to a component of the
large subunit. These findings suggest MPV17L2 con-
tributes to the biogenesis of the mitochondrial ribo-
some, uniting the two subunits to create the transla-
tionally competent monosome, and provide evidence
that assembly of the small subunit of the mitochon-
drial ribosome occurs at the nucleoid.
INTRODUCTION
The mammalian mitochondrial proteome comprises 1500
or more gene products. The deoxyribonucleic acid (DNA)
inside mitochondria DNA (mtDNA) contributes only 13
of these proteins, and they make up ∼20% of the subunits
of the oxidative phosphorylation (OXPHOS) system, which
produces much of the cells energy. All the other proteins
of the organelle are nuclear encoded, synthesized in the cy-
tosol and then imported into the mitochondria. A substan-
tial number of these proteins have roles associated with the
structure, production and maintenance of the respiratory
chain and adenosine triphosphate synthase, being struc-
tural components or assembly factors thereof, or contribu-
tors to mtDNA maintenance and expression. However, the
precise role of many mitochondrial proteins remains un-
known, limiting our understanding of the organelle’s role
in physiological and disease processes.
The construction of a mitochondrial proteome database
comprising over 1000 proteins has facilitated the discov-
ery of mitochondrial disease-genes, such asMPV17 (1). In
2006, the MPV17 protein, previously assigned as having
peroxisomal localization (2), was predicted instead to be a
mitochondrial protein (3) and then experimentally shown to
localize exclusively to the inner membrane of mitochondria
(3). In the latter study, MPV17 dysfunction was also linked
to a form of mitochondrial DNA depletion syndrome (3),
and later withmultiple deletions of mtDNA (4,5). However,
neither the function of the MPV17 protein, nor the mecha-
nism leading to mtDNA perturbation is currently known.
In mammals, MPV17 is homologous to three other pro-
teins: MPV17-like protein (MPV17L), MPV17-like 2 pro-
tein (MPV17L2 or FKSG24) and peroxisomal membrane
protein 2 (PXMP2). Existing literature suggest a peroxi-
somal localization for PXMP2p (6,7) and dual localiza-
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tion of MPV17L in mitochondria and peroxisomes (8,9).
A recent study proposes that PXMP2 forms a constitu-
tively open pore within the peroxisomal membrane, which
is voltage-independent and displays weak cationic selectiv-
ity (10). Hitherto, nothing was known about the function of
MPV17L2. However, previous studies of the mitochondrial
proteome have assigned it as a mitochondrial protein based
on Bayesian integration of genomics data (1) and a green
fluorescent protein (GFP) tagged version of the protein is
targeted to the mitochondria (11).
Here we resolve the phylogenetic relationships of the
four mammalianMPV17-related proteins, and report a first
characterization of the homologue most similar toMPV17,
namely MPV17L2. We show that MPV17L2 is an inner
mitochondrial membrane protein that is associated with
mitochondrial nucleic acids. Specifically, MPV17L2 inter-
acts with the large subunit of the mitochondrial ribosome
and the monosome, and when its expression is reduced by
ribonucleic acid (RNA) interference, the ribosome is dis-
rupted and translation in the mitochondria is impaired, in-
dicating MPV17L2 plays an important role in ribosomal
biogenesis in the organelle.
MATERIALS AND METHODS
Plasmid preparation
Human complementary DNA (cDNA) specifying MPV17
(IMAGE: 5217853) was introduced into Flp-In T-REx hu-
man embryonic kidney cells (HEK293T, Life Technologies)
to establish inducible, transgenic cell lines. The transgene
carried a carboxy-terminal linker sequence followed by oc-
tapeptide (DYKDDDDK) (FLAG) and StrepII tags.
Cell culture and transfection
HEK293T cells were grown in Dulbecco’s Modified Ea-
gle’s Medium (Life Technologies) supplemented with 10%
fetal bovine serum (Fetal bovine serum (FBS), Hyclone)
1% penicillin and streptomycin (PS, Life Technologies), 15
g/ml BlasticidinS and 100 g/ml Zeocin (Biosciences).
For the generation of inducible transgenic MPV17 FLAG-
StrepII cell lines, transfection was mediated using Lipo-
fectamine 2000 (Life Technologies) according to manufac-
turer’s guidelines. Following transfection, cells underwent
selection in DMEM supplemented with 10% tetracycline-
free FBS (Biochrom), 1% PS, 15g/ml BlasticidinS and 100
g/ml hygromycinB (Sigma). Gene expression was induced
by adding doxycycline (Sigma) to the culturemediumwith a
final concentration of 10 ng/ml for 24 h. HEK293T  0 cells
were generated as previously described for avian cells (12).
HeLa cells were cultured in DMEM supplemented with
10% FBS, 1% PS and 50 g/ml uridine. For transient de-
pletion of mtDNA, parental HEK293Tcells were cultured
in standard media described above supplemented with 100
ng/ml ethidium bromide for 96 h.
RNA interference ofMPV17L2
Reverse transfection knockdown experiments were per-
formed using 100 000 HeLa cells in antibiotic-free me-
dia containing 50 g/ml uridine, using either siRNA tar-
geting MPV17L2 (Ambion Silencer Select A2: s392421,
5′-CUGCACU ACUGGUACUUGU-3′ A3: s39422, 5′-
CCCATGAAGATGGATGATCA-3′, or Origene O1: 5′-
UGAUCAUCCAUCUUCAUGG-3′) or an unrelated non-
targeting siRNA (Ambion Silencer select siRNA negative
control 4390846) at 10 nM delivered using Lipofectamine
RNAiMax (Life Technologies) according tomanufacturer’s
specifications. HeLa cells underwent either one or two
rounds of siRNA treatment, with the second transfection
performed 72 h after the initial transfection. After 6 days,
cells were harvested and processed for quantitative real-
time PCR (Q-PCR), immunoblotting, sucrose gradient, im-
munofluorescence or mitochondrial translation analysis.
Immunofluorescence and electron microscopy
HeLa cells grown on glass coverslips were treated with
100 nM MitoTracker R© Red for 30 min, fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) and
permeabilized with 0.3% Triton X-100 in PBS contain-
ing 5% FBS. After permeabilization, samples were blocked
with 5% FBS in PBS and incubated with the indicated
primary antibodies: anti-DNA (dilution 1:150; Progen),
MRPS27 (dilution 1:200, Proteintech), MRPS18 (dilution
1:200, Proteintech), MRPL45 (dilution 1:200, Proteintech).
After three washes, slides were incubated with the fol-
lowing secondary antibody: AlexaFluor R©-488 goat–anti-
mouse antibodies or AlexaFluor R© 568 donkey anti-rabbit
(dilution: 1:1000; Molecular Probes). Finally, cover slips
were washed with PBS and mounted on glass slides by in-
version over ProLong R© Gold Antifade Reagent that in-
cludes 4’,6-diamidino-2-phenylindole (DAPI) nuclear stain.
In preparation for electron microscopy HeLa cells were
fixed in 2% glutaraldehyde/2% paraformaldehyde for 30
min, and then incubated for 1 h with 1% osmium tetroxide
using 0.1 M sodium cacodylate buffer pH 7.2, at room tem-
perature. The samples were then dehydrated and embedded
in Epon resin. Sections were stained with ethanolic uranyl
acetate and Reynold’s lead citrate, and viewed with a Jeol
100EX Transmission electron microscopy (TEM). Images
were captured with a Gatan Orius 1000 Charge-coupled de-
vices (CCD).
Mitochondrial isolation, protease protection assay, carbonate
extraction and iodixanol gradient fractionation
Mitochondria were isolated as described (13). Briefly,
HEK293T cells were disrupted by homogenization in hy-
potonic buffer (20 mM HEPES pH 8, 5 mM KCl, 1.5
mMMgCl2 and 2 mM DTT), and mixed with a mannitol–
sucrose buffer to final concentrations of 210 mMmannitol,
70 mM sucrose, 20 mM HEPES pH 8 and 2 mM EDTA
(1 × MSH), prior to purification of mitochondria by dif-
ferential centrifugation. The protease protection assay was
modified from (14). Briefly, 50 g aliquots of mitochon-
dria were resuspended in 0.1 ml of hypotonic buffer (20
mM HEPES-OH pH 7.6) in the presence or absence of
5 g/ml of trypsin and incubated at 30◦C for the indi-
cated times. Trypsin digestionwas quenched by the addition
of 1.5 mg/ml SBTI (Soya bean Trypsin Inhibitor, Sigma)
and further incubation on ice for 10 min. Mitochondria
from all samples were then isolated by centrifugation, and
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washed twice with MSH buffer before resuspension with
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) loading buffer. Sensitivity of proteins to
trypsin digestion was assayed with SDS-PAGE followed by
immunoblotting with the indicated antibodies.
For carbonate extraction of mitochondrial proteins, 2 mg
of HEK293T mitochondria were treated with either 0 or
100 mM sodium carbonate pH 11.5. A fraction of the mito-
chondria were treated additionally with 0.1 or 1% sodium
deoxycholate for 30 min on ice/4◦C. All samples were then
centrifuged at 122 000 g for 30 min and the supernatant
and pellet fractions were analysed by immunoblotting, after
trichloroacetic acid (TCA) precipitation.
For iodixanol gradient fractionation, 1000 g supernatant
from lysed mitochondria was loaded onto 20–42.5% dis-
continuous iodixanol (Optiprep, Sigma) gradients (Gradi-
ent buffer: 20 mM HEPES pH 7.8, 1 mM EDTA, 50 mM
NaCl, 2 mMDTT, 0.05%DDMwith 1:50 (v/v) Roche pro-
tease inhibitor) and centrifuged at 100 000 g for 14 h at
4◦C. Resulting gradients were fractionated into 0.5 ml frac-
tions collected from the bottom of the tube. mtDNA was
extracted by phenol–chloroform extraction and resolved on
1% agarose gels.
Immunoprecipitation of ICT1-FLAG and MRPS27-FLAG
Mitochondria isolated from HEK293T cells overexpress-
ing ICT1-FLAG or MRPS27-FLAG were lysed with 50
mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100. Immunoprecipitation was performed with
anti-FLAG M2 beads following manufacturer’s instruc-
tions (Sigma). Elution was performed with the 3X FLAG
peptide (Sigma).
Analysis of mitochondrial ribosomes on sucrose gradients
For the analysis of separate large and small mitochondrial
ribosomal subunits, whole cells were solubilized in lysis
buffer (50mMTris pH7.4, 150mMNaCl, 1mMEDTA, 1%
Triton), supplementedwith 1× proteinase inhibitor cocktail
without EDTA (Roche) and loaded onto linear 10–30% su-
crose gradients (gradient buffer: 50 mM Tris-HCl pH 7.2,
10 mMMg(OAc)2, 80 mMNH4Cl, 100 mMKCl) and cen-
trifuged at 100 000 g for 2 h 15 min at 4◦C. Gradients were
collected as 22 × 100 l fractions from the top of the gradi-
ent. Intact mitochondrial ribosomes were fractionated us-
ing a protocol adapted (15). Mitochondria were isolated
from four 80% confluent 175 cm2 flasks using EDTA free
buffers. Then, 1 mg lots of mitochondria were lysed in 260
mMsucrose, 100mMKCl, 20mMMgCl2, 10mMTris-HCl
(pH 7.5), 1% Triton X-100, EDTA-free complete protease
inhibitor (Roche), and 0.08 U/ml RNAsin (Promega) for
20 min on ice. Mitochondrial lysates were cleared by cen-
trifugation (10 000 g for 45 min at 4◦C) and loaded on a
10–30% linear sucrose gradient containing 100 mM KCl,
20 mMMgCl2, 10 mM Tris-HCl (pH 7.5), and EDTA-free
complete protease inhibitor (Roche). After centrifugation at
71 000 g for 15 h at 4◦C, 15 fractions of 750l were collected
from the top of the gradient using an automated gradient
harvester (Brandel) and subjected to western blot analysis.
Quantitative real-time PCR for estimation of mtDNA copy
number andMPV17L2 mRNA level
Q-PCR was performed on 25 ng lots of total cellular
DNA, using portions of the COII and cytochrome b
genes for mtDNA and APP1 for nuclear DNA. Primers
with the following sequences were employed: COXII,
forward 5′-CGTCTGAACTATCCTGCCCG-3′, re-
verse 5′-TGGTAAGGGAGGGATCGTTG-3′, probe
5′-CGCCCTCCCATCCCTACGCATC-3′; Cytb for-
ward 5′-GCCTGCCTGATCCTCCAAAT-3′, reverse
5′-AAGGTAGCGGATGATTCAGCC-3′, probe 5′-
CACCAGACGCCTCAACCGCCTT-3′. Probes contained
a 5′ FAM fluorophore and a 3′ TAMRA quencher (Sigma
Genosys). For the nuclear reference gene, a validated
(20×) APP TaqMan Copy Number Assay master mix was
used (Applied Biosystems ID Hs00339475 cn) contain-
ing primers and probe. For MPV17L2 messenger RNA
(mRNA) abundance estimation, total RNA was extracted
usingTRIzol reagent (Life Technologies) according toman-
ufacturer’s instructions. DNA was removed with the Turbo
DNase free kit (Applied Biosystems) and reverse transcrip-
tion was performed using Omniscript reverse transcriptase
(QIAGEN) with random hexamer primers (QIAGEN)
to produce single-stranded cDNA template. Primers and
probes to MPV17L2 (TaqMan, Life Technologies, Assay
ID: Hs00261946 m1, FAM reporter and non-fluorescent
quencher) and endogenous control GAPDH (Sigma
Genosys, Probe: FAM reporter and TAMRA quencher: 5′-
[6FAM]ATTTGGTCGTATTGGGCGCCTGGT[TAM]-
3′, forward: 5′-GGTGAAGGTCG GAGTCAACG-3′
reverse: 5′-CAGAGTTAAAAGCAGCCCTGGT-3′) were
used to estimate MPV17L2 mRNA level using 100ng
sscDNA in each reaction. TaqMan gene expression assay
mix (Life Technologies) and default cycling parameters on
the Applied Biosystems (ABI) sequence detection system
7700 were used.
SDS-PAGE, western blotting and immunoblotting detection
Protein samples were prepared in 1× Laemmli loading
buffer, heated at 42◦C for 45 min and resolved on the
indicated PAGE gels (Novex). After electrophoresis re-
solved proteins were transferred to a polyvinylidene fluo-
ride membrane. After blocking with 5% non-fat dry milk
in PBS with 0.1% (v/v) Tween-20 (PBST) membranes
were incubated overnight with primary antibodies. Pri-
mary antibodies employed for immunoblotting were: rab-
bit anti-AIF (Apoptosis-inducing factor) (1:4000, Milli-
pore), rabbit anti-C-terminal of ATAD3 (1:50 000, was
raised against recombinant protein produced in-house),
rabbit anti-N-terminal of ATAD3 (1:30 000, was raised
against recombinant protein produced in-house), rabbit
anti-C7-orf30 (1:250, Abcam), mouse anti-Core1 (1:2000,
Invitrogen), mouse anti-Core2 (1:2000, Invitrogen), mouse
anti-Cox1 (1:1000, Mitoscience), mouse anti-Cox2 (1:1000,
Mitoscience), rabbit anti-ERAL1 (1:1000, Proteintech),
mouse anti-FLAG (1:1000, Sigma), mouse anti-GAPDH
(1:20 000, Sigma), rabbit anti-HSP60 (1:10 000, Ab-
cam), rabbit anti-LRPPRC (1:3000, SantaCruzBiotechnol-
ogy), rabbit anti-MPV17 (1:500 Proteintech), rabbit anti-
MPV17L2 (1:500, Abcam), goat anti-MRPL3 (1:1000, Ab-
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cam), rabbit anti-MRPL11 (1:1000, Cell Signaling); rabbit
anti-MRPL12 (1:1000, Proteintech), rabbit anti-MRPL13
(1:1000, Proteintech), rabbit anti-MRPL45 (1:1000, Gene-
tex), rabbit anti-MRPL48 (1:1000, Proteintech), rabbit anti-
MRPL58 (Ict1, 1:1000, Proteintech), rabbit anti-MRPS17
(1:1000, Proteintech), rabbit anti-MRPS18B (1:1000; PT-
GLAB); rabbit anti-MRPS22 (1:1000, Proteintech), rab-
bit anti-MRPS26 (1:1000, Abcam), rabbit anti-MRPS27
(1:1000, Proteintech), mouse anti-MRPS29 (DAP3, 1:1000,
Abcam), mouse anti-NDUFA9 (1:1000, Mitoscience), rab-
bit anti-TFAM (1:50 000 a kind gift of Prof. R. Wies-
ner), rabbit anti-prohibitin (1:500 BioLegend), rabbit anti-
TOM20 (1:20 000, Santa Cruz), rabbit anti-TIM23 (1:2000,
Sigma), mouse anti-VDAC1 (1:4000, Abcam). Secondary
HRP antibodies were obtained from Promega and used at
1:5000 in 5% milk in 1× PBS/0.1% Tween. Immunoblots
were developed using enhanced chemiluminescence (ECL)
and ECL Prime (GE Healthcare).
[ 35S]-methionine in cell labelling of mitochondrial proteins
Mitochondrial translation products in cultured cells were
labelled as described previously (16). HeLa cells, trans-
fected with non-targeting siRNAs or siRNAs targeting
MPV17L2, or mock transfected, were washed twice with
methionine/cysteine-free DMEM (Sigma) supplemented
with 2 mML-glutamine, 96g/ml cysteine and 5% (v/v) di-
alyzed FBS followed by 10 min incubation in this media at
37◦C. Cytosolic translation was subsequently inhibited by
incubating the cells for 20 min with 100 g/ml emetine di-
hydrochloride (Sigma). 100Ci [35S]-methioninewas added
and labelling was performed for 1 h at 37◦C, after which
cells were washed three times with PBS (Life Technolo-
gies) before lysis in 1× PBS, 0.1% n-dodecyl--D-maltoside
(DDM), 1% SDS, 50 units benzonase (Novagen), 1:50 (v/v)
Roche protease inhibitor cocktail. Twenty micrograms lots
of protein were resolved via SDS-PAGE (Novex) and the
radiolabelled proteins were detected by Phosphorimager of
the dried gels (TyphoonMolecular Imager FX, GEHealth-
care).
Phylogenic analysis
The MPV17 protein family was assembled via a PSI-
Blast search (default parameters), starting with the hu-
manMPV17 protein and iterating until convergence. Mem-
bers of the family were selected to delineate the origin
of the four members of the family in mammals (MPV17
MPV17L, MPV17L2 and PMP22) and based on the pres-
ence of experimental data (mainly protein locations, ob-
tained from SUBcellular location database for Arabidopsis
proteins (SUBA) (http://www.suba.bcs.uwa.edu.au)). Sub-
sequently, a protein sequence alignment was created with
ClustalX (17), followed by minor manual modifications.
Based on this alignment, the most appropriate model for
MPV17 sequence evolution (LG + G + F) and the corre-
sponding tree were selected with ProtTest (18) after which
the bootstrap values were obtained with PhyML (19).
Subfractionation of yeast mitochondrial proteins
Sym1 tagged with a triple HA tag at its C-terminus was
expressed in Saccharomyces cerevisiae. Mitochondria were
isolated as described previously (20). After rabiolabelling of
mitochondrial translation products with 35S-methionine in
organello, the mitochondria were lysed with 1% Triton X-
100, 50 mM NH4Cl, 5 mM MgSO4, 1 mM phenylmethyl-
sulfonyl fluoride, 20 mMHEPES, pH 7.4. After a clarifying
spin (10 min at 25 000 g, 4◦C), the lysate was loaded on a
linear sucrose gradient (12 ml, 10–34% sucrose, 0.1% Triton
X-100, 50 mM NH4Cl, 5 mMMgSO4 and 20 mM HEPES
pH 7.4). The samples were centrifuged in an SW41 rotor
(Beckman) at 33 000 rpm for 5.5 h at 4◦C. Subsequently, 16
fractions were collected and containing proteins were pre-
cipitated with TCA.
RNA extraction and northern blotting
Total RNA fromHEK293T cells was extracted using Trizol
(Invitrogen) via chloroform extraction and isopropanol
precipitation according to manufacturer’s specifications.
Five to eight micrograms of total RNA was resolved on
1% agarose gels containing 0.7 M formaldehyde, in 1×
MOPS (3-(N-morpholino) propanesulfonic acid) buffer.
Resulting gels were imaged under ultraviolet (UV). RNA
was transferred onto MagnaProbe nylon membrane
(GE) in 5× SSC, 10 mM NaOH and RNA was UV-
crosslinked to the membrane. Membranes were probed
with radioactively labelled PCR fragments. PCR products
were labelled with 32P-dCTP (Hartmann Analytic) using
DNA Polymerase I Klenow Fragment (New England
Biolabs). Forward and reverse primers for probes were as
follows 5′-3′: ND1, CATGGCCAACCTCCTACTCCT-
CATT and GGCAGGAGTAATCAGAGGTGTTCTTG;
A6/COII, TATTCCTAGAACCAGGCGACCTGC and
TTTCGTTCATTTTGGTTCTCAGGGT TG; CYTB,
CCCCCATAAATAGGAGAAGGCTTAGAAG and
CCCGATGTGTAGGAAGA GGCAG; 18S rRNA
GTTGGTGGAGCGATTTGTCT and GGCCTCAC-
TAAACCATCCAA.
RESULTS
MPV17 belongs to a family of evolutionary conserved pro-
teins
To map the origin of the human MPV17 homologues and
to resolve the orthology relationships between them and
MPV17 homologues from other species, we derived an
MPV17 phylogeny (Figure 1A). The comparisons of the
MPV17 related proteins from human, from model organ-
isms with protein localization data, and from represen-
tative taxa in the metazoa support their classification as
a small conserved family. The phylogeny indicates that a
gene duplication event before the radiation of the eukary-
otes produced a MPV17/L/L2 clade on one hand and
a PXMP2 clade on the other hand. Later gene duplica-
tion events early in metazoan evolution gave rise to the
MPV17,MPV17L andMPV17L2 clades and the phylogeny
suggests that MPV17L and MPV17L2 are sister groups
of each other. Pairwise comparisons of the three human
8504 Nucleic Acids Research, 2014, Vol. 42, No. 13
Figure 1. The MPV17 family of proteins. (A) Maximum likelihood phylogeny of the MPV17 protein family, with an emphasis on the origin of the human
members of the protein family. Experimental localization data for proteins are indicated with the branches. Bootstrap values above 90 out of 100 are shown.
The phylogeny indicates an early separation of theMPV17 clade from the PXMP2 clade, and a later, metazoan origin of theMPV17L andMPV17L2 clades.
Overall there is a general pattern of lineage specific duplications throughout the eukaryotes, leading, for example, to 10 members of the MPV17 protein
family inDrosophila melanogaster (not all of which are shown). Protein location within an orthologous group tends to be conserved, but gene duplications
often leads to the acquiring of a new location (60), as can be observed for the PXMP2/MPV17 gene duplication at the origin of the eukaryotes and the
gene duplication within the fungi that potentially give rise to a new, vacuolar location of YOR292C (61). (B) Sequence alignment of the four members of
the human MPV17 family. Alignment was based on a ClustalX alignment of the protein family. Colour coding of the level of conservation was based on
Jalview (62). (C) Levels of sequence identity/similarity among the human MPV17 family members, the ordering of the proteins along the horizontal axis
is identical as that along the vertical axis. Pairwise levels of sequence identity/similarity were based on global pairwise sequence alignment, using default
parameters in the EMBOSS package (63). MPV17L2 has a slightly higher level of sequence identity and sequence similarity to MPV17 than MPV17L has
to MPV17.
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amino acid sequences show that MPV17L2 has a higher
level of sequence similarity and identity toMPV17 than has
MPV17L (Figure 1B and C), which is reflected in the rela-
tively long branch lengths in the MPV17L clade compared
to theMPV17L2 clade (Figure 1A). Therefore, we began the
study of the wider MPV17 family with MPV17L2, with the
ultimate aim of understanding both its function and that
of other family members, especially MPV17, deficiencies of
which cause mtDNA maintenance disorders.
Human MPV17L2 is an integral mitochondrial membrane
protein
To determine whether or not mammalian MPV17L2 is a
mitochondrial protein, HEK293T cells were fractionated
and analysed by immunoblotting, using an antibody to
MPV17L2. A protein of the expected size, enriched in mito-
chondria, cross-reacted with the MPV17L2 antibody, sug-
gesting that MPV17L2 is targeted to the mitochondria. No
signal was detected in the post-mitochondrial supernatant
(Figure 2A). To establish the location of MPV17L2 within
the organelle, mitochondria fromHEK293T cells were sub-
jected to hypotonic shock and mild proteolysis treatment.
This procedure degrades contaminants, outer mitochon-
drial membrane (OMM), and intermembrane space (IMS)
proteins, as well as any part of an innermitochondrial mem-
brane (IMM) protein that projects into the IMS. Its effec-
tiveness is demonstrated here by the digestion of TOM20
and AIF, markers of OMM and IMS respectively, the IMS
portion of the IMM protein TIM23 (21) and the amino
terminal portion of most ATAD3A molecules (14) (Fig-
ure 2B). In contrast, the mitochondrial inner membrane
remained intact, as evidenced by the preservation of the
IMM protein NDUFA9, and a mitochondrial matrix pro-
tein LRPPRC (Figure 2B). MPV17L2 is fully resistant to
the treatment, indicating it resides in the IMM, or the mi-
tochondrial matrix. To distinguish between these last two
possibilities, trypsin-treated mitochondria from HEK293T
cells were subjected to alkaline stripping and deoxycholate
treatment to lyse the mitochondria and release matrix
proteins and peripheral membrane proteins into solution
(22,23). MPV17L2 was detected in the insoluble pellet frac-
tion (P), with little or none in the supernatant (S), under
all conditions tested (Figure 2C). The mRNA binding pro-
tein LRPPRC (24) was released into the supernatant by
the alkaline treatment, whereas the established IMM pro-
tein prohibitin 1 (PHB1) (25) remained in the pellet (Fig-
ure 2C). Together the results indicate that MPV17L2 is
firmly embedded in the IMM. The related protein MPV17
is also resistant to alkaline and deoxycholate stripping (3),
and like MPV17L2 it is resistant to limited proteolysis af-
ter rupturing of the OMM (Figure 2B). In light of these
data, it can be concluded that no part (tail or loop) of
MPV17 or MPV17L2 projects into the IMS sufficiently to
permit trypsin degradation, which is compatible with both
the amino and carboxyl terminal tails (of both proteins)
facing the matrix. Nevertheless, experimental data from a
tagged form of Sym1, the yeast mitochondrial orthologue
ofMPV17, suggest that theC-terminus of the protein ‘faces’
the IMS (26,27). Because we had available a carboxy ter-
minal tagged form of MPV17, additional experiments were
performed to clarify the orientation of this protein. Hypo-
tonic shock and trypsin treatment of mitochondria isolated
from cells expressing the recombinant protein resulted in di-
gestion of part, but not all, of the FLAGand StrepII tags, as
the size of the product was larger than endogenous MPV17
(Figure 2D). Thus, as with Sym1: at least the carboxyl ter-
minus of recombinant MPV17 faces the IMS. However, re-
combinant MPV17, and by extrapolation the endogenous
protein, is embedded in the IMM or otherwise arranged to
protect it from trypsin digestion (Figure 2D). Clearly this
finding has implications for the study of IMMproteins gen-
erally: the inability to digest one or other part of an IMM
protein cannot be taken as evidence that it is matrix facing.
Decreased MPV17L2 expression causes mitochondrial
swelling and nucleoid aggregation
An idea of the contribution of a protein to mitochondrial
structure and function can often be gleaned by examining
the effect of gene silencing on the organelles. After down-
regulation of MPV17L2 expression in HeLa cells (Supple-
mentary Figure S1), with any of three specific siRNAs, there
were many prominent protrusions or nodules in the mito-
chondrial network, unlike cells transfected with non-target
oligonucleotides (Figure 3A). To investigate the ultrastruc-
ture of the abnormal mitochondria the HeLa cells were
analysed by electron microscopy. After MPV17L2 gene si-
lencing many mitochondria were enlarged and the cristae
were sparse or completely absent, in contrast to the cells
transfected with a non-target dsRNA, (Figure 3B). In some
mitochondria of cells depleted of MPV17L2 the cristae
were swollen, which might well precede cristae loss (Figure
3B). Detection of mtDNA by immunocytochemistry indi-
cated that the enlarged nodules in the mitochondria coin-
cided with high concentrations of DNA (Figure 3C). Hence
mtDNA distribution or segregation appears to be impaired
in the absence ofMPV17L2. Althoughmany nucleoids were
larger than normal, similar to TFAM gene silencing (28),
decreased MPV17L2 expression did not lead to mtDNA
depletion within the timeframe of the experiment (Supple-
mentary Figure S2A), unlike TFAM repression (28). In-
stead, there was ∼70% increase in mtDNA copy number
in response to MPV17L2 gene silencing and no marked
change in mitochondrial transcript levels (Supplementary
Figure S2B).
MPV17L2 co-fractionates with mitochondrial nucleoids on
iodixanol gradients and is not detectable in cells devoid of
mtDNA
To determine if the mtDNA phenotypes associated with
MPV17L2 depletion (Figure 3) reflected a direct interac-
tion between the two mitochondrial nucleoprotein com-
plexes were resolved on iodixanol gradients (IG) and anal-
ysed by immunoblotting. MPV17L2 co-fractionated with
mitochondrial nucleoids (Figure 4A), and in cells lacking
mtDNAMPV17L2 was undetectable (Figure 4B). Further-
more, the abundance of MPV17L2 decreased in line with
mtDNA copy number, when mtDNA depletion was in-
duced by ethidium bromide (EB) treatment of HEK293T
cells for 72 h (Figure 4C); in these circumstances the
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Figure 2. MPV17L2 is an integral membrane protein of the mitochondrial inner membrane. (A) Cellular fractionation of HEK293T cells. Proteins from
whole cell lysate (WCL, 20 g), post-mitochondrial supernatant (PM s/n 20 g) and mitochondrial lysate (ML: 20 g) were analysed by immunoblotting
with the indicated antibodies. Mitochondrial markers were NDUFA9 (nuclear encoded subunit of Complex 1) and COX1 (mtDNA encoded subunit of
cytochrome c oxidase), whereas GAPDH antibody was used as an indicator of cytosolic protein content. MPV17L2 was found to be enriched in the
mitochondrial lysate. (B) Time course of limited proteolysis of HEK293T parental mitochondria in hypotonic buffer. Proteins were resolved by 4–12%
gradient, or 12 or 16% linear SDS-PAGE according to the mass of the target protein and analysed by immunoblotting, using antibodies against the OMM
(TOM20), the IMS (AIF), the IMM (TIM23, the N-terminal and C-terminal domains of ATAD3, NDUFA9,MPV17) and the matrix (LRPPRC) proteins
(see text for details). (C) Analysis of the solubility MPV17L2. Isolated mitochondria were extracted with sodium carbonate at pH 11.5, with 0, 0.1 or
1% sodium deoxycholate (NaDOC). In all conditions MPV17L2 and PHB1 remained in the pellet (P), whereas LRPPRC was released to the supernatant
(S) after sodium carbonate extraction; M, untreated mitochondria. (D) As (B), except that mitochondria were isolated from HEK293T cells not-induced
(NI, lanes 1–5) or induced (I, lanes 6–10), to express recombinant MPV17-FLAG-STREPII. Mitoplasts were analysed by 12 or 16% SDS-PAGE and
immunoblotted with MPV17 (black arrow) and the FLAG epitope (dashed arrow) antibodies. The antibodies against TIM23, the N- and C-termini of
ATAD3 were used as IMS and IMM controls, respectively. The lowest panel is a long exposure of the immunoblot for endogenous MPV17.
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Figure 3. MPV17L2 gene silencing affects mitochondrial and nucleoid morphology. After two rounds of transfection with one of three siRNAs targeting
MPV17L2 or a non-target (NT) dsRNA, the mitochondria of HeLa cells were stained with MitoTrackerTM Red (A) (see ‘Materials and Methods’ section
for details). MitoTrackerTM dense areas (nodules) were scored in 100 control (NT) and 100 MPV17L2 siRNA-treated cells (n = 2 experiments, 50 cells
per experiment). The same phenotype of increased numbers of distended mitochondria was observed on five independent experiments but not quantified.
(B) Mitochondria of HeLa cells treated with no RNA (Mock) (a), or non-targeting dsRNA (NT) (b), or dsRNAs targetingMPV17L2 (siR2) (c–d) were
visualized by electron microscopy. Arrowheads indicate mitochondria devoid of cristae (c and d), or with distended cristae (e and f). The scale bars in
panel a–d are 0.4 m. The images in panels e and f were enlarged to show the altered cristae structure in more detail (1.5×). (C) Confocal microscopy of
HeLa cells transfected with non-targeting (NT) orMPV17L2-specific dsRNA (siR1). Mitochondria were stained with MitoTrackerTM Red, the DNA in
the cytoplasm was detected by immunocytochemistry (green) and nuclear DNA was detected by DAPI staining (blue).
mtDNA resolves lower on the iodixanol gradient, and this
was also true of MPV17L2. The dependence of MPV17L2
on the presence of mtDNA suggests it is involved in DNA
maintenance or expression. In contrast to MPV17L2, the
bulk of the MPV17 protein resolves much higher on the IG
than mtDNA (Figure 4A), and it persists in cells lacking
mtDNA (Figure 4B).
MPV17L2 co-sediments with the large subunit of the mito-
chondrial ribosome and the monosome
Mitochondrial ribosomes and associated proteins coin-
cide or overlap with mitochondrial nucleoids on iodixanol
gradients (13), and the mitochondrial ribosomal protein
MRPL3 shows the same dependence on, and association
with, mtDNA as MPV17L2 (Figure 4A, 4B). Hence, the
properties of MPV17L2 described above were compatible
with it interacting primarily with the mitochondrial ribo-
some. Therefore, sucrose gradients (SG) were used to sepa-
rate mitochondrial ribosomes from the nucleoids and frac-
tions of the gradients were immunoblotted with antibod-
ies toMRPL3 andMRPS18B to determine the distribution
of the large mitochondrial ribosomal subunit (mtLSU) and
the small mitochondrial ribosomal subunit (mtSSU), re-
spectively. Based on these markers MPV17L2 co-sediments
with the mtLSU and not the mtSSU (Figure 5A).
As a further test of the association of MPV17L2 with
the mitochondrial ribosome, immunoprecipitation was per-
formed using HEK293T cells expressing ICT1-FLAG, a
component of the mtLSU (29), or MRPS27-FLAG, a
component of the mtSSU (30). Endogenous MPV17L2
was greatly enriched in immunoprecipitations using ICT1-
FLAG (Figure 5B), whereas it was undetectable when
MRPS27-FLAG was used as bait. Hence, the immunopre-
cipitation experiments substantiate the sucrose gradient re-
sults indicatingMPV17L2 associates with themtLSU. They
also corroborated the sucrose-gradient results with respect
to MPV17, the related family protein: MPV17 did not co-
fractionate with either the large or the small mitochon-
drial ribosomal subunit (Figure 5A) and nor was it enriched
in the immunoprecipitations of ICT1-FLAG or MRPS27-
FLAG (Figure 5B).
Having learnt that MPV17L2, and not MPV17, inter-
acts with the mitochondrial ribosome, this distinguishing
feature was explored in budding yeasts which have a sin-
gle mitochondrial MPV17 homologue, Sym1. To this end,
a sequence cassette coding for an HA tag was integrated
into the chromosome downstream of the Sym1 locus re-
sulting in the expression of an HA-tagged Sym1 protein.
Fractionation of mitochondrial proteins on sucrose gradi-
ents revealed that Sym1 was not associated with the mito-
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Figure 4. MPV17L2 distribution overlaps with mtDNA on iodixanol gradients, whilst in cells lacking mtDNAMPV17L2 is not detectable. (A) Mitochon-
drial 1000 gmax supernatants from HEK293T cells were fractionated on 20–42.5% iodixanol gradients, the DNA content of each fraction was determined
by ethidium bromide staining after agarose gel electrophoresis. Proteins were separated on 4–12% gradient, or 12 or 16% linear SDS-PAGE, proteins were
detected by immunoblotting with the indicated antibodies (see text for details). (B) Immunoblots of total cellular protein from HEK293T cells with (+)
and without (0) mtDNA. ATAD3, ATPase family AAA domain-containing protein 3; COX2, Cytochrome c Oxidase subunit 2; Core1, nuclear subunit
Complex III; HSP60, Heat Shock Protein 60; MRPL3, MPV17, homologous protein to MPV17L2; Mitochondrial Ribosomal Large Subunit Protein 3;
MRLS18B, Mitochondrial Ribosomal Small Subunit Protein 18B; MRLS27, Mitochondrial Ribosomal Small Subunit Protein 27; TFAM, mitochondrial
Transcription Factor A. (C) HEK293T cells were treated with or without 100 ng/ml ethidium bromide (EB) for 72 h. Mitochondrial lysates (ML) (see
‘Materials andMethods’ section) were fractionated on 20–42.5% iodixanol gradients. DNA or protein was extracted after fraction collection and analysed
by Southern hybridization (mtDNA) and immunoblotted with the indicated antibodies.
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Figure 5. MPV17L2 interacts with the large subunit of the mitochondrial ribosome and the monosome. (A) HEK293T cells were lysed and their con-
tents fractionated on 10–30% sucrose gradients. The distribution of representative mitochondrial nucleoid and ribosomal proteins was determined by
immunoblotting (see ‘Materials and Methods’ section and text for details). (B) HEK293T cells expressing MRPS27-FLAG (a component of mt-SSU)
or ICT1-FLAG (a component of mtLSU) were lysed and subjected to immunoprecipitation with FLAG-antibody. The lysates (‘input’) and eluates were
analysed by immunoblotting with the indicated antibodies. (C) HeLa cell mitochondria lysed in EDTA-free buffer were fractionated on 10–30% sucrose
gradients. The migration of the monosome and the mtLSU and mtSSU were inferred from the distribution of individual ribosome components detected
by immunoblotting using the indicated antibodies.
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chondrial ribosomes (Supplementary Figure S3). Thus, it
is unlikely that Sym1 incorporates all the functions of the
two human proteins MPV17 and MPV17L2, and the latter
probably gained a new function after the gene duplication
event.
The experiments described above were carried out in
buffer containing EDTA and without addition of high con-
centration of magnesium. Therefore, mitochondria from
HeLa cells were isolated in EDTA-free buffer, disrupted in
the presence of 20 mM magnesium and sedimented on su-
crose gradients (see ‘Materials andMethods’ section) to de-
termine if MPV17L2 associates with the 55S mitochondrial
ribosome. Co-fractionation of a proportion of MRPL13,
MRPS27 and MRPS18 (Figure 5C, fraction 11) confirmed
the preservation and location of the monosomes on the gra-
dient, and a similar proportion of the MPV17L2 protein
was also present in fraction 11, suggesting that it physically
interacts with fully assembled mitochondrial ribosomes.
MPV17L2 gene silencing inhibits mitochondrial translation
Because the sucrose gradient and immunoprecipita-
tion analyses suggested a physical interaction between
MPV17L2 and mitoribosomes, we next sought to deter-
mine if MPV17L2 contributes to mitochondrial protein
synthesis. Transient RNA interference with each one of
the three dsRNAs targeting MPV17L2, or one of the two
random dsRNA sequences, were performed, prior to an
assessment of mitochondrial translation capacity in living
cells (see ‘Materials and Methods’ section). The synthesis
of nascent mitochondrial proteins was markedly reduced
in cells transfected with siRNAs targeting MPV17L2,
compared to controls (Figure 6A and Supplementary
Figure S1B). Furthermore, MPV17L2 gene silencing
produced marked decreases in the levels of both nuclear
and mitochondrially encoded components of the OXPHOS
system (Figure 6B).
MPV17L2 gene silencing destabilises the mitochondrial ribo-
some
We next determined the effect of gene silencing of
MPV17L2 on the steady-state level of ribosomal proteins
in HeLa cell mitochondria. Five of six mtLSU compo-
nents screened were depleted in response to MPV17L2
RNAi, as was the ribosomal assembly factor C7orf30 (31–
33) that associates with the mtLSU (Figure 6C). Less ex-
pectedly, several components of the mtSSU were also ad-
versely affected by MPV17L2 knockdown (Figure 6D).
The depletion of the mtSSU components was more strik-
ing when the samples were fractionated on sucrose gradi-
ents under conditions that preserve the monosome (Figure
7); several mtSSU proteins were at the limits of detection
(MRPS17, MRPS22, MRPS29). More informatively, much
of the MRPS27, whose steady-state level was not markedly
decreased by MPV17L2 knockdown (Figure 6D), was re-
located to the top of the gradient, far above the mtSSU
or the monosome (Figure 7). The decreases in the com-
ponent parts of the mitochondrial ribosome (Figure 6C
and D) were mirrored by the amount of monosome, which
was markedly decreased as a result of MPV17L2 silencing
Figure 6. MPV17L2 gene silencing inhibits mitochondrial protein syn-
thesis and decreases the abundance of OXPHOS and mitochondrial ribo-
somal proteins. Expression ofMPV17L2 was repressed by RNA interfer-
ence in HeLa cells (see ‘Materials and Methods’ section) and the effects
on mitochondrial translation (A), steady state levels of OXPHOS subunits
and MPV17L2 (B), and MRPs and C7orf30 (C), and (D) determined. (A)
mitochondrial protein synthesis was assayed by incubation of the cells in
35S-methionine, after emetine treatment to block cytosolic protein synthe-
sis. Proteins were separated by 12% PAGE and radiolabelled proteins de-
tected by PhosphorImaging. Equal loading of the gels was confirmed by
Coomassie blue staining. (B) Protein levels of MPV17L2 and subunits of
respiratory chain complexes were analysed by immunoblotting in control
cells transfected with no RNA (MT), a random dsRNA (NT) or one of
two siRNAs specific forMPV17L2 (siR1 and siR2). GAPDH was used as
a loading control. (C) Steady-state levels of C7orf30 and mtLSU proteins,
and (D) mtSSU components. Mitochondria lysates of HeLa cells, treated
as in (A) and (B), were separated by SDS-PAGE and immunobloted for
the indicated MRPs and VDAC1 as loading control.
(Figure 7). However, there was a residual apparently fully
assembled population of mtLSU, based on its sedimenta-
tion properties (Figure 7), which contained the remaining
MPV17L2. This suggests that there were no mtLSUs lack-
ing MPV17L2, but the residual protein was insufficient to
support monosome formation, at least at the normal rate.
Because C4orf14 (NOA1) is involved in mtSSU bio-
genesis and it interacts with mitochondrial nucleoids, it
has been proposed that the small subunit is assembled
at the mitochondrial nucleoid (34). Furthermore, disso-
ciation of the mtSSU from the nucleoid is presumed to
follow its association with the mtLSU (34). The desta-
bilization of the mtSSU in response to depletion of the
mtLSU-associated protein MPV17L2 (Figures 5 and 7),
suggests that MPV17L2 might mediate unification of the
small and large subunits of the mitochondrial ribosome. If
true, a dearth of MPV17L2 would prolong the association
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Figure 7. MPV17L2 gene silencing impairs mitochondrial ribosome assembly. Mitochondrial lysates from HeLa cells treated with a random dsRNA
(NT) or a specific siRNA for MPV17L2 (siR2) were separated on a 10–30% isokinetic sucrose gradient and fractions analysed by immunoblotting with
antibodies toMPV17L2, mtLSU (MRPL11,MRPL13,MRPL45), mtSSU (MRPS17,MRPS18B,MRPS22,MRPS26,MRPS27,MRPS29) and C7orf30.
Inset: protein levels of MPV17L2 and the loading control VDAC1 in mitochndrial lysates of control and MPV17L2 siRNA treated cells.
8512 Nucleic Acids Research, 2014, Vol. 42, No. 13
of mtSSU with mitochondrial nucleoids. In this scenario,
the observed decreases in mtSSU (Figures 6D and 7) re-
flect disassembly or blocked assembly of the 28S subunit
to limit the detrimental consequences of the extended con-
tact between nucleoids and mtSSUs. To test this hypoth-
esis we analysed the distribution of the mtLSU, mtSSU
andmtDNA in cells treated withMPV17L2 and non-target
siRNAs. Immunocytochemistry ofMRPL45,MRPS27 and
MPRS18 indicated that both the ribosomal large and small
subunits were distributed widely in the mitochondria of
control cells. AfterMPV17L2 knockdown the distribution
of the residual mtLSU (MRPL45) was unaltered, whereas
the remaining mtSSU (MRPS27 and MPRS18) was con-
centrated in a small number of large foci (Figure 8). The
effect on the mtSSU was strikingly similar to the effect on
the mtDNA, and there was substantial colocalization and
juxtaposition of DNA and mtSSU foci (Figure 8). As elab-
orated in the ’Discussion’ section, these findings suggest the
mtSSU is assembled at the nucleoid and prolonging the in-
teraction causes mtDNA aggregation.
DISCUSSION
The current study identifies MPV17L2 as an inner mito-
chondrial membrane protein with a key role in mitochon-
drial protein synthesis, as it is required for the assembly
and stability of the mitochondrial ribosome. The depen-
dence of MPV17L2 on mtDNA (Figure 4) and its associa-
tion with themitoribosome distinguish it fromMPV17, and
suggest it has evolved a new function after a gene duplica-
tion event. Hence, MPV17 and MPV17L2 are paralogues.
Both are nuclear genes that influence mtDNA metabolism,
MPV17 contributes to mtDNA maintenance (3), whereas
MPV17L2 has a role in mitochondrial protein synthesis
(this report). Notwithstanding these differences, the im-
munocytochemistry data indicate that there is a major dis-
turbance of mtDNAorganization whenMPV17L2 is scarce
(Figures 3B and 8), which in view ofMPV17L2’s ribosomal
association suggests perturbed ribosome-nucleoid interac-
tions (13,34,35).
Numerous features of the mitochondrial translation sys-
tem suggest it has a prokaryotic origin. For instance, many
of the proteins linked to mitochondrial ribosomal biogen-
esis and assembly have clear bacterial homologs and or-
thologs (13,31,32,34,36–38). In contrast, MPV17L2 does
not appear to have any bacterial counterpart linked to pro-
tein synthesis. Nevertheless, the protein is concentrated in
SG fractions containing the mtLSU or the monosome, with
no appreciable free pool of MPV17L2, and there is no
contamination of this region of the SG with its paralogue
MPV17 (Figure 5A). The ICT1 immunoprecipitation ex-
periments were equally clear, with a substantial enrichment
ofMPV17L2, and no detectableMPV17, or a subunit of the
highly abundant cytochrome c oxidase (Figure 5B). There-
fore, the function of MPV17L2 can with some confidence
be assigned to the workings of the mitochondrial ribosome,
and this is corroborated by disruption to the mitochondrial
ribosome when its expression is low (Figure 7), and impair-
ment of mitochondrial translation (Figure 6A and Supple-
mentary Figure S1B).
The association of MPV17L2 with the mtLSU on SGs
and its immunoprecipitation with ICT1 are features shared
with C7orf30 (31,32), a protein which has been proposed
to participate in the assembly of the mtLSU (33). More-
over, MPV17L2 silencing induced a marked depletion of
C7orf30 (Figure 6C), and the effects of C7orf30 gene si-
lencing display considerable overlap with those reported
here for MPV17L2. MRPL58 (ICT1) was one of the most
severely affected subunits of the mtLSU both in the case of
C7orf30 knockdown (see Figure 4 of (33)) and MPV17L2
knockdown (Figure 6C). The mtSSU was also affected by
bothC7orf30 andMPV17L2 gene-silencing (Figures 6C, D
and 7; and Figure 4 of (33); and Figure 5F of (31). There-
fore, we infer that MPV17L2 cooperates with C7orf30 to
assemble themitochondrial ribosome. Furthermore, the ad-
verse effects on the mtSSU of MPV17L2 depletion can be
explained by the prolonged association of the mtSSU with
the nucleoid. This interpretation is predicated on the idea
that the mtSSU is assembled at the mitochondrial nucleoid
(34) and that the completion of monosome assembly is a
required step for the separation of the mtSSU and the nu-
cleoid. Hence, decreases in the population of mtLSU will
extend the time that the mtSSU and the nucleoid remain
bound together. Prolonged coupling could well interfere
with other aspects of nucleoid function and maintenance,
and so the failure to form themonosome can explain the im-
pairment of nucleoid distribution (Figures 3C and 8). An-
other hypothesis stems from the recent suggestion that both
the small and the large ribosomal subunits are in the initial
stages assembled at the nucleoid (39); thus ifMPV17L2 was
involved in incipient mtLSU assembly, its absence might
perturb assembly of both ribosomal subunits. However,
what argues against this idea is that MRPL45, one of the
reported ‘nucleoid-enrichedmtLSU components’ identified
by Bogenhagen and colleagues (39), was distributed nor-
mally in the absence of MPV17L2 (Figure 8). Alternatively,
mtSSU depletion owing to a problem relating to themtLSU
might reflect a counting mechanism for the two subunits,
whereby a decrease in one invariably leads to downregu-
lation of the other. If true, the counting mechanism over-
reacts, as MPV17L2 knockdown depletes the mtSSU to a
greater extent than the mtLSU (Figure 7); and this last hy-
pothesis cannot explain the nucleoid aggregation caused by
MPV17L2 depletion.
Mitochondrial translation products are highly hydropho-
bic and are inserted into the inner membrane as they
are synthesized (40,41). In yeast, the machinery that cou-
ples translation to membrane insertion includes Oxa1,
Mba1 and Mdm38 (LETM1), and these proteins physi-
cally connect ribosomes to the inner membrane (42–47).
In bovine mitochondrial ribosomes, a large additional pro-
tein mass has been proposed close to the polypeptide exit
tunnel (PET) (48). More recently, a structural component,
MRPL45, has been identified at the PET and it has been
proposed to anchor themtLSU to the innermembrane (49).
The tight association ofMPV17L2 with the mtLSU and the
fact that it is firmly embedded in the IMMmakeMPV17L2
a good candidate for a role at the PET. In particular, it might
interact with the nascent polypeptides to facilitate their exit
from the ribosome and their insertion into the OXPHOS
complexes of the mitochondrial inner membrane. Any in-
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Figure 8. MPV17L2 gene silencing causes condensation of mtSSU proteins in foci that frequently coincide or overlap with enlarged mitochondrial nu-
cleoids. HeLa cells treated with a random dsRNA (NT) or a specific siRNA forMPV17L2 (siR2) were analysed by confocal microscopy with antibodies
to MRPS18B, MRPS27 and MRPS45 (red), the DNA was detected by anti-DNA (green) antibody. Co-localization of the ribosomal-specific red signal
and DNA-specific green signal appears yellow in the merged images.
terruption to this process could cause ribosome stalling and
consequently severely impair mitochondrial translation, as
observed when MPV17L2 is silenced (Figure 6A and Sup-
plementary Figure S1B). The cristae alterations observed
in mitochondria ofMPV17L2 knockdown (Figure 3B) are
similar to those observed for another protein linked to the
mtLSU, CRIF1 (50). Hence, this might be a general conse-
quence of defects in the apparatus of mitochondrial protein
synthesis, and it will be of interest to learn whether this is
true also of C7orf30, and if it extends tomtSSU-related pro-
teins, such as C4orf14 (34) and ERAL1 (36,38).
The location of MPV17L2 may also serve to stabilize
or position the mtLSU and the monosome by linking
them to the inner mitochondrial membrane. MPV17L2
may be assisted in this by LETM1 (mdm38), with which
it shares a number of features. Both are inner membrane
proteins that are associated with mitochondrial ribosomes
(43,46,51) and the morphological abnormalities observed
in MPV17L2 downregulation are similar to LETM1 de-
ficient mitochondria (52,53). These similarities strengthen
the view that MPV17L2 plays a role in the interlinked pro-
cesses of translation and assembly of OXPHOS complexes
(40,41). LETM1 has another role that might be pertinent
to the function of MPV17L2, and that of the wider MPV17
family. LETM1 is proposed to act as K+/H+ exchanger
or calcium proton antiporter (54–56). One member of the
MPV17 family, PXMP2 has been proposed to form a chan-
nel in vitro (10) and Sym1 displayed channel activity in an-
other study (26). Hence, the MPV17 family members might
all act as channels with different substrate specificities. If
true, a major challenge for the future is to identify the sub-
strate(s) of each family member. There could be some re-
dundancy between MPV17 and MPV17L2, as the expres-
sion of MPV17 increased in  0 cells (Figure 4B), which
might compensate to some degree for the loss ofMPV17L2.
In any case, the increased expression of MPV17 in human
cells lacking mtDNA, recapitulates the behaviour of its ho-
mologue in yeast (57), thereby indicating that the protein
has a function beyond DNAmaintenance in human as well
as in yeast.
Finally, although there was no decrease in mtDNA copy
number after 6 days of MPV17L2 gene silencing (Supple-
mentary Figure S2A), defective mtDNA segregation lead-
ing to mtDNA depletion is a likely long-term consequence
of nucleoid aggregation. Moreover, this is predicted to be
true of any mutant protein that inhibits the uncoupling of
the mtSSU from the nucleoid. Hence, mitochondrial ribo-
somal biogenesis defects might underpin quite a number
of the, as yet, unexplained cases of mtDNA depletion syn-
drome, or provoke neurodegeneration (58). Furthermore, in
light of our new findings, translation, rather than transcrip-
tion (59), could be the key to the age-related accumulation
of deleterious mtDNA variants.
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